Idinvest Partners and Kurma Life Sciences Partners announce the success of IPO of Prosensa Holding B.V
On Friday June 28th, Prosensa Holding B.V. (Prosensa) initiated its first trading day on the Nasdaq New York, US. Prosensa is the second Idinvest Biotech portfolio company completing a market listing this year. Earlier in 2013, Erytech Pharma, a French company specialized in innovative therapeutic approach for cancers was admitted on NYSE Euronext Paris.
Download the pdf file